Isavuconazole

Chemical formula: C₂₂H₁₇F₂N₅OS  Molecular mass: 437.47 g/mol 

Therapeutic indications

Isavuconazole is indicated for:

Invasive aspergillosis, mucormycosis

Population group: only adults (18 years old or older)

Isavuconazole is indicated in adults for the treatment of:

  • invasive aspergillosis
  • mucormycosis in patients for whom amphotericin B is inappropriate

Consideration should be given to official guidance on the appropriate use of antifungal agents.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Isavuconazole is contraindicated in the following cases:

Ketoconazole

Ketoconazole

Ritonavir

Ritonavir

Moderate and strong CYP3A4/5 inducers

at least one of
CYP3A4 inducers
Cytochrome P-450 CYP3A5 moderate inducers
Cytochrome P-450 CYP3A5 strong inducers

Familial short QT syndrome

Short QT syndrome

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2020: CRESEMBA Powder for concentrate for solution for infusion
Summary of Product Characteristics (SPC) 2020: CRESEMBA Hard capsule
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈